Skip to main content
Equibles

STEPHENS INC /AR/

Position in EXEL — Exelixis, Inc.

CIK 757657 LITTLE ROCK, AR
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$493,988
-$90,774 QoQ
Shares Held
9,079
-33.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#428
of 756 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEPHENS INC /AR/ holds $5,988,068 across 12 Biotechnology names. EXEL ranks #6 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,900 $1,440,517
2 TECH
BIO-TECHNE Corp
 12,036 $850,343
3 TWST
Twist Bioscience Corp
 5,167 $531,580
4 REGN
Regeneron Pharmaceuticals, Inc.
 831 $518,161
5 LGND
Ligand Pharmaceuticals Inc
 1,625 $513,646
6 EXEL
Exelixis, Inc.
This page 		9,079 $493,988
7 ALNY
Alnylam Pharmaceuticals, Inc.
 1,638 $493,087
8 HALO
Halozyme Therapeutics, Inc.
 4,954 $387,749

All Filings in EXEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $493,988 9,079
2026-03-31 $584,762 13,634
2025-12-31 $604,985 13,803
2025-09-30 $369,387 8,944
2025-06-30 $395,529 8,973
2025-03-31 $2,709,854 73,398
2024-12-31 $297,668 8,939
2024-09-30 $251,429 9,689
2024-03-31 $205,596 8,664
2023-12-31 $208,521 8,692
2023-09-30 $198,113 9,067
2023-06-30 $174,397 9,126
2023-03-31 $181,599 9,356
2022-12-31 $145,097 9,046
2022-09-30 $141,841 9,046
2022-06-30 $190,627 9,156
2022-03-31 $216,589 9,554
2021-12-31 $178,266 9,752
2021-09-30 $163,792 7,748
2021-06-30 $95,818 5,259
2021-03-31 $85,412 3,781
2020-12-31 $6,683 333
2020-09-30 $17,090 699
2020-06-30 $13,911 586
2020-03-31 $3,547 206